Video

Coming Soon, HER2-Positive Breast Cancer: A Review of Data from the SABCS 2021 Virtual Meeting

Author(s):

Virginia G. Kaklamani, MD, DSc

Virginia Kaklamani, MD, DSc, shares her excitement for an upcoming OncLive® "The TALK" program focusing on HER2-positive breast cancer updates from the SABCS 2021 Virtual Meeting.

Related Videos
Sheldon M. Feldman, MD
Sheldon M. Feldman, MD
In this episode of OncChats: Empowering Community Cancer Care, Dr. Rai emphasizes the importance of community outreach and support for patients with cancer, highlighting the need for holistic care that addresses both physiological and psychological aspects of treatment while reinforcing the value of strong relationships between primary care physicians and specialists.
In this episode of OncChats: Empowering Community Cancer Care, Dr. Woodworth sheds light on the “Road to Recovery” survivorship program at Henry Mayo, which supports cancer survivors by providing them with fitness, education, and mental health resources, and underscores the importance of mentorship programs for community providers to ensure equitable cancer care.
In this episode of OncChats: Empowering Community Cancer Care, Drs Woodworth and Rai, discuss their collaborative approach to cancer screening, emphasizing the importance of community efforts and individual assessments in integrating genetic testing and screenings into routine practice.
In this episode of OncChats: Empowering Community Cancer Care, experts discuss the significance of community-based cancer care, emphasizing that most cancers are diagnosed locally and highlighting the importance of collaboration between primary care physicians and specialists to provide optimal education and treatment.
Sunil Adige, MD
Margaret E. Gatti-Mays, MD, MPH, FACP
Sunil Adige, MD
Related Content
BioZorb Markers and BioZorb LP Markers | Image Credit: © Axel Kock - stock.adobe.com
October 30th 2024

FDA Advises Against Use of BioZorb Markers in Breast Cancer and Other Indications

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Sheldon Feldman, MD, Montefiore Einstein
October 30th 2024

Breast Cancer Awareness Month Spotlights Progress With Personalized Medicine

MedNews Week
September 4th 2024

Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer

Jairam Krishnamurthy, MD, FACP, of University of Nebraska Medical Center
October 25th 2024

Frontline Palbociclib Opens the Door to Subsequent CDK4/6 Inhibition in Metastatic Breast Cancer

Xiaojia Wang, MD, oncologist, Department of Breast Medical Oncology, Cancer Hospital, University of Chinese Academy of Sciences, Zhejiang Cancer Hospital
October 24th 2024

First-Line Ivonescimab Plus Chemotherapy Demonstrates Efficacy in Advanced TNBC